An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results Scientific Data Adverse Event Reporting in Clinical Trials In 2023, the FDA banned 19 peptides from compounding pharmacies. No specific safety incident. No clear signal. Just a regulatory decision that pushed millions of patients toward gray market suppliers and overseas Immune Related Adverse Events Associated with Immune Checkpoint Blockade New England Journal of Medicine